Summary
The pharmacokinetics of lofepramine, an imipramine analogue, have been studied by administering single oral doses to volunteers, determination of plasma levels of lofepramine and desmethylimipramine after ten days of oral administration to patients, and by relating plasma levels to the effect on uptake of noradrenaline by isolated rat irides and brain slices of plasma samples collected during treatment. The results indicate that lofepramine undergoes pronounced first pass elimination and that desmethylimipramine is a major metabolite of it. During steady-state conditions the plasma level of lofepramine fluctuates considerably between doses. A linear relation was found between inhibition of neuronal uptake of noradrenaline and the plasma concentration of desmethylimpramine. No effect was seen on the uptake of 5-hydroxytryptamine in brain slices incubated in patients' plasma which suggests that neither lofepramine nor its metabolites formedin vivo in man affect neuronal uptake of this amine. Lofepramine belongs to the group of tricyclic anti-depressants which preferentially inhibit noradrenaline uptake.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexanderson, B.: Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single dose plasma-level data. Europ. J. clin. Pharmacol.4, 82–91 (1972 a)
Alexanderson, B.: Pharmacokinetics of desmethylimipramine and nortriptyline in man after single and mutiple oral doses — a cross-over study. Europ. J. clin. Pharmacol.5, 1–10 (1972 b)
Borgå, O., Azarnoff, D.L., Plym Forshell, G., Sjöqvist, F.: Plasma protein binding of tricyclic antidepressants in man. Biochem. Pharmacol.18, 2135–2143 (1969)
Borgå, O., Hamberger, B., Malmfors, T., Sjöqvist, F.: The role of plasma protein binding for the inhibitory effect of nortriptyline on the neuronal uptake of noradrenaline. Clin. Pharmacol. Ther.11, 581–588 (1970)
Eriksoo, E., Rohte, O.: On the chemistry and pharmacology of a new potential antidepressant, Leo 640. Arzneimittel-Forsch.20, 1561–1569 (1970)
Ervik, M., Walle, T., Ehrsson, H.: Quantitative gas chromatographic determination of nanogram levels of desipramine in serum. Acta pharm. suecica7, 625–634 (1970)
Freyschuss, U., Sjöqvist, F., Tuck, J.R.: Tyramine pressor effects in man before and during treatment with nortriptyline or ECT: correlation between pharmacokinetics and effect of nortriptyline. Pharmacol. Clin.2, 72–78 (1970)
Hamberger, B., Tuck, J.R.: Effect of tricyclic antidepressants on the uptake of noradrenaline and 5-hydroxytryptamine by rat brain slices incubated in buffer or human plasma. Europ. J. clin. Pharmacol.5, 229–235 (1973)
Hamberger, B., Tuck, J.R.:3H-nortriptyline uptake and tissue-bindingin vitro and its effect on3H-noradrenaline uptake. Experientia (Basel) (accepted for publication 1975)
Jonsson, G., Hamberger, B., Malmfors, T., Sachs, C.: Uptake and accumulation of3H-noradrenaline in adrenergic nerves of rat iris, effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition. Europ. J. Pharmacol.8, 58–72 (1969)
Jørgensen, A.: A gas chromatographic method for the determination of amitriptyline and nortriptyline in human serum. Acta pharmacol. (Kbh.)36, 79–90 (1975)
Plym Forshell, G.: Studies on the distribution and excretion of (3H14C) labelled lofe-pramine in the rat. Xenobiotica5, 73–82 (1975)
Siwers, B., Tuck, J.R., Freyschuss, U., Azarnoff, D.L., Sjöqvist, F.: A novel approach to the phase-I clinical trial of tricyclic antidepressant drugs. In: Abstracts for Fourth International Congress of Pharmacology, July 14 – 18, 1969, pp 432–433, Basel Switzerland. Basel: Schwabe & Co. 1969
Siwers, B., Freyschuss, U., Hamberger, B., Tuck, J.R., Malmfors, T., Sjöqvist, F.: A quantitative approach to the initial clinical trial of tricyclic antidepressants: a comparison of Leo 640 and nortriptyline. Europ. J. clin. Pharmacol.3, 12–17 (1970)
Sjöqvist, F.: A pharmacokinetic approach to the treatment of depression. Int. Pharmacopsychiat.6, 147–169 (1971)
Tuck, J.R., Kahan, E., Siwers, B.: Biological and pharmacokinetic evidence for generic equivalence of three imipramine preparations: comparison with a new imipramine analogue. Acta pharmacol. (Kbh.)32, 304–313 (1973)
Tuck, J.R., Punell, G.: Uptake of (3H) 5-hydroxytryptamine and (3H) noradrenaline by slices of rat brain incubated in plasma from patients treated with chlorimipramine, imipramine or amitriptyline. J. pharm. Sci.25, 573–574 (1973)
Åsberg, M., Bertilsson, L., Tuck, J.R., Cronholm, B., Sjöqvist, F.: Indolemine metabolites in the cerebro-spinal fluid of depressed patients before and during treatment with nortriptyline. Clin. Pharmacol. Ther.14, 277–286 (1973)
Author information
Authors and Affiliations
Additional information
Lofepramine = Leo 640 = N-methyl-N-[4-Chlorobenzoyl-methyl-3-(10.11-dihydro-5H-dibenz (b, t) azepin-5-yl]-propylamine
Rights and permissions
About this article
Cite this article
Plym Forshell, G., Siwers, B. & Tuck, J.R. Pharmacokinetics of lofepramine in man: Relationship to inhibition of noradrenaline uptake. Eur J Clin Pharmacol 9, 291–298 (1976). https://doi.org/10.1007/BF00561663
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561663